Comparative Efficacy of Dose Regimens in Enzyme Replacement Therapy of Type I Gaucher Disease

Barton, 1991, Replacement therapy for inherited enzyme deficiency—Macrophage-targeted glucocerebrosidase for Gaucher's disease, N. Engl. J. Med., 324, 1464, 10.1056/NEJM199105233242104 Grabowski, 1998, Enzyme therapy for Gaucher disease: The first five years, Blood Rev., 12, 115, 10.1016/S0268-960X(98)90023-6 Brady, 1966, Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease, J. Clin. Invest., 45, 1112, 10.1172/JCI105417 Brady, 1994, Development of effective enzyme therapy for metabolic storage disorders, Int. Pediatr., 9, 175 Cox, 1997, Gaucher's disease: Clinical features and natural history, 657 Figueroa, 1992, A less costly regimen of alglucerase to treat Gaucher's disease, N. Engl. J. Med., 327, 1632, 10.1056/NEJM199212033272304 Pastores, 1993, Enzyme therapy in Gaucher disease type I: Dosage efficacy and adverse effects in 33 patients treated for 6 to 24 month, Blood, 82, 408, 10.1182/blood.V82.2.408.408 Zimran, 1994, Low dose enzyme replacement therapy for Gaucher ‘s disease: Effects of age, sex, genotype, and clinical features on response to treatment, Am. J. Med., 97, 3, 10.1016/0002-9343(94)90042-6 Zimran, 1995, Replacement therapy with imiglucerase for type 1 Gaucher's disease, Lancet, 345, 1479, 10.1016/S0140-6736(95)91038-7 Zimran, 1993, Home treatment with intravenous enzyme replacement therapy for Gaucher disease: An international collaborative study of 33 patients, Blood, 82, 1107, 10.1182/blood.V82.4.1107.1107 Zimran, 1993, Low dose high-frequency enzyme replacement therapy for very young children with severe Gaucher disease, Br. J. Heamatol., 85, 783, 10.1111/j.1365-2141.1993.tb03224.x Niederau, 1994, Glucocerebrosidase for treatment of Gaucher ‘s disease: First German long-term result study, J. Hepatol., 21, 610, 10.1016/S0168-8278(94)80109-6 Bembi, 1994, Enzyme replacement treatment in type 1 and type 3 Gaucher's disease, Lancet, 344, 1679, 10.1016/S0140-6736(94)90462-6 Grabowski, 1995, Enzyme therapy in type 1 Gaucher disease: Comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources, Ann. Int. Med., 122, 33, 10.7326/0003-4819-122-1-199501010-00005 Lehman, 1975 Hollak, 1995, Individualised low dose alglucerase therapy for type 1 Gaucher's disease, Lancet, 345, 1474, 10.1016/S0140-6736(95)91037-9 Figueroa, 1992, A less costly regimen to treat Gaucher ‘s disease, N. Engl. J. Med., 327, 1632, 10.1056/NEJM199212033272304 Beutler, 1995, The clinical course of treated and untreated Gaucher disease. A study of 45 patients, Blood Cells Mol. Dis., 21, 86, 10.1006/bcmd.1995.0012 Fallet, 1992, Enzyme augmentation in moderate to life-threatening Gaucher disease, Pediatr. Res., 31, 496, 10.1203/00006450-199205000-00018 Mistry, 1992, Successful treatment of bone marrow failure in Gaucher's disease with low dose modified glucocerebrosidase, Q. J. Med., 83, 541 Zimran, 1995, Enzyme replacement therapy in type 1 and type 3 Gaucher's disease, Lancet, 345, 451, 10.1016/S0140-6736(95)90432-8 Mistry, 1997, A practical approach to diagnosis and management of Gaucher's disease, 817 MacKenzie, 1998, Enzyme replacement therapy for Gaucher disease: The early Canadian experience, CMAJ, 159, 1273 Charrow, 1998, Gaucher disease recommendations on diagnosis, evaluation and monitoring, Arch. Intern. Med., 158, 1754, 10.1001/archinte.158.16.1754 Elstein, 1998, Low dose low frequency imiglucerase as a starting regimen on enzyme replacement therapy for patients with type I Gaucher disease, Q. J. Med., 91, 483, 10.1093/qjmed/91.7.483 Stowens, 1985, Skeletal complications of Gaucher disease, Medicine, 64, 310, 10.1097/00005792-198509000-00003 Mankin, 1990, Metabolic bone disease in patients with Gaucher disease, 730 Hill, 1993, MRI of multiple platyspondyly in Gaucher disease: Response to enzyme replacement therapy, J. Comp. Assist. Tomogr., 17, 806, 10.1097/00004728-199309000-00026 Rosenthal, 1995, Enzyme replacement therapy for Gaucher disease: Skeletal response to macrophage-targeted glucocerebrosidase, Pediatrics, 96, 629, 10.1542/peds.96.4.629 Elstein, 1996, Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement, Blood Cells Mol. Dis., 22, 104, 10.1006/bcmd.1996.0016 Barton, N. W, Brady, R. O, and, Dambrosia, J. M. 1993, 328, 1564. [letter]